Ureteral Injury Clinical Trial
Official title:
Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy
The primary objective is to describe the safety and efficacy of intravenous sodium fluorescein to visualize ureteral efflux during intraoperative cystoscopy after total laparoscopic hysterectomy. Secondary objective is to report on surgeon's satisfaction with the overall use of sodium fluorescein.
Thirty patients (n=30) ongoing a total laparoscopic hysterectomy in a tertiary gynecological reference center will be included in this prospective descriptive study.Once hysterectomy is completed, a 10 % solution of sodium fluorescein at a 0,25 ml dose will be injected before performing diagnostic cystoscopy. Time from injection to fluorescent visualization will be recorded as well as coloration density. Adverse events are collected in the operating room, in the recovery room, before patient's discharge and through a home survey. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03432572 -
Investigating Oral Agents for Urine Staining to Facilitate Intraoperative Observation of Ureteral Jets
|
Early Phase 1 | |
| Withdrawn |
NCT02757417 -
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
|
N/A | |
| Recruiting |
NCT04732403 -
Ureteral Jets and Patient Positioning Study
|
N/A | |
| Completed |
NCT04695951 -
Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract
|
Phase 2 | |
| Recruiting |
NCT05477043 -
Ureteral Patency After Uterosacral Ligaments Suspension
|